Modulation of testicular receptor 4 activity by mitogen-activated protein kinase-mediated phosphorylation

M D Mostaqul Huq1, Pawan Gupta, Nien-Pei Tsai

  • 1Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA.

Insights

Testicular receptor 4 (TR4) activity is regulated by phosphorylation, not ligands. Mitogen-activated protein kinase (MAPK) phosphorylation of TR4

Area of Science:

  • Molecular Endocrinology
  • Nuclear Receptor Signaling
  • Signal Transduction

Background:

  • Testicular receptor 4 (TR4) is an orphan nuclear receptor with demonstrated functions.
  • The mechanism regulating TR4 activity in the absence of specific ligands remains unknown.

Purpose of the Study:

  • To investigate the ligand-independent regulation of TR4 biological activity.
  • To identify the role of post-translational modifications, specifically phosphorylation, in TR4 function.

Main Methods:

  • Mass spectrometry-based proteome analysis to identify TR4 phosphorylation sites.
  • Site-directed mutagenesis to assess the functional significance of phosphorylation.
  • Recruitment assays for corepressors and coactivators.
  • Validation using wild-type and mutant TR4 in target gene regulation studies.

Main Results:

  • Identified three MAPK-mediated phosphorylation sites on TR4's AF-1 domain: Ser(19), Ser(55), and Ser(68).
  • Phosphorylation at Ser(19) and Ser(68) is functionally significant.
  • MAPK-mediated phosphorylation converts TR4 into a repressor by recruiting RIP140.
  • Dephosphorylation converts TR4 into an activator by recruiting PCAF.
  • TR4 mutants mimicking constitutive phosphorylation or dephosphorylation demonstrated altered apoE gene regulation.

Conclusions:

  • TR4 activity is regulated by a ligand-independent mechanism involving MAPK-mediated phosphorylation of its AF-1 domain.
  • Phosphorylation status dictates TR4's interaction with corepressors and coactivators, thereby controlling its transcriptional activity.
  • This provides novel insights into the regulation of orphan nuclear receptors.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...